Mumbai, Nov. 6 -- The board of Cohance Lifesciences at its meeting held on 06 November 2026 has approved the appointment of Dr. Kuber Jagdale (DIN: 12037580) as an Additional Director, designated as Chief

Technical Officer & Executive Director for a period of 5 (five) years effective from 7 November 2026 till 6 November 2031.

Published by HT Digital Content Services with permission from Capital Market....